We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Octave Specialty Group to Report Q2 Earnings: What to Expect
Read MoreHide Full Article
Key Takeaways
Octave Specialty is expected to post $81 million in Q2 revenues and a loss of 1 cent per share.
Premium growth, fees, cross-selling and ArmadaCare are likely to support second-quarter results.
Lower yields and higher commissions, and claims and administrative costs may dampen OSG's results.
Octave Specialty Group, Inc. (OSG - Free Report) is expected to witness an improvement in its top and bottom lines when it reports second-quarter 2026 results on Aug. 6, after the closing bell.
The Zacks Consensus Estimate for OSG’s second-quarter revenues is pegged at $81 million, indicating 47.4% growth from the year-ago reported figure.
The consensus estimate for the bottom line is pegged at a loss of 1 cent per share, indicating a year-over-year improvement of 95.5%. The Zacks Consensus Estimate for OSG’s second-quarter bottom line witnessed no movement in the past seven days.
Solid Earnings Surprise History
Octave Specialty’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 464.4%.
What the Zacks Model Unveils for OSG
Our proven model does not conclusively predict an earnings beat for Octave Specialty this time around. This is because a stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) that increases the chances of an earnings beat. That is not the case here, as you can see below.
You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Earnings ESP: OSG has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at a loss of 1 cent.
Octave Specialty Group, Inc. Price and EPS Surprise
Revenues in the to-be-reported quarter are likely to have benefited from higher net premiums earned, commissions, and servicing and other fees. Net premiums earned likely increased on the growth of new and existing programs, including programs carrying higher retention ratios. However, the nonrenewal of certain programs may have partly offset the improvement.
Octave’s continued emphasis on expanding products and geographic reach, increasing cross-selling, strengthening carrier relationships, and enhancing its digital data infrastructure likely supported second-quarter performance. Its property-focused MGAs remain diversified across the United States, the United Kingdom and Bermuda, with an emphasis on low-catastrophe-exposed lines and niche small and medium-sized enterprise markets. This positioning likely limited the impact of volatility in property markets. Meanwhile, favorable pricing in higher-hazard classes probably supported casualty operations.
Commission revenues are expected to have increased, reflecting organic growth in premiums placed and the contribution from the ArmadaCare acquisition. However, net investment income likely declined because of lower yields on corporate short-term investments.
Stocks to Consider
Some multiline insurance stocks with the right combination of elements to deliver an earnings beat this time around are:
MetLife (MET - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank of 3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $2.30 per share, indicating a 13.9% year-over-year increase.
MET’s earnings beat estimates in three of the last four reported quarters, while missing in one.
Oscar Health (OSCR - Free Report) has an Earnings ESP of +0.02% and a Zacks Rank of 1 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at 43 cents per share, indicating a year-over-year decrease of 143.3%.
OSCR’s earnings beat estimates in three of the last four reported quarters, while missing in one.
Prudential Financial (PRU - Free Report) has an Earnings ESP of +0.85% and a Zacks Rank of 3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.42 per share, indicating a year-over-year decrease of 4.5%.
PRU’s earnings beat estimates in three of the last four reported quarters and missed in one.
View the Zacks #1 Rank List
Image: Bigstock
Octave Specialty Group to Report Q2 Earnings: What to Expect
Key Takeaways
Octave Specialty Group, Inc. (OSG - Free Report) is expected to witness an improvement in its top and bottom lines when it reports second-quarter 2026 results on Aug. 6, after the closing bell.
The Zacks Consensus Estimate for OSG’s second-quarter revenues is pegged at $81 million, indicating 47.4% growth from the year-ago reported figure.
The consensus estimate for the bottom line is pegged at a loss of 1 cent per share, indicating a year-over-year improvement of 95.5%. The Zacks Consensus Estimate for OSG’s second-quarter bottom line witnessed no movement in the past seven days.
Solid Earnings Surprise History
Octave Specialty’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 464.4%.
What the Zacks Model Unveils for OSG
Our proven model does not conclusively predict an earnings beat for Octave Specialty this time around. This is because a stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) that increases the chances of an earnings beat. That is not the case here, as you can see below.
You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Earnings ESP: OSG has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at a loss of 1 cent.
Octave Specialty Group, Inc. Price and EPS Surprise
Octave Specialty Group, Inc. price-eps-surprise | Octave Specialty Group, Inc. Quote
Zacks Rank: OSG carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Factors Likely to Shape OSG’s Q2 Results
Revenues in the to-be-reported quarter are likely to have benefited from higher net premiums earned, commissions, and servicing and other fees. Net premiums earned likely increased on the growth of new and existing programs, including programs carrying higher retention ratios. However, the nonrenewal of certain programs may have partly offset the improvement.
Octave’s continued emphasis on expanding products and geographic reach, increasing cross-selling, strengthening carrier relationships, and enhancing its digital data infrastructure likely supported second-quarter performance. Its property-focused MGAs remain diversified across the United States, the United Kingdom and Bermuda, with an emphasis on low-catastrophe-exposed lines and niche small and medium-sized enterprise markets. This positioning likely limited the impact of volatility in property markets. Meanwhile, favorable pricing in higher-hazard classes probably supported casualty operations.
Commission revenues are expected to have increased, reflecting organic growth in premiums placed and the contribution from the ArmadaCare acquisition. However, net investment income likely declined because of lower yields on corporate short-term investments.
Stocks to Consider
Some multiline insurance stocks with the right combination of elements to deliver an earnings beat this time around are:
MetLife (MET - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank of 3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $2.30 per share, indicating a 13.9% year-over-year increase.
MET’s earnings beat estimates in three of the last four reported quarters, while missing in one.
Oscar Health (OSCR - Free Report) has an Earnings ESP of +0.02% and a Zacks Rank of 1 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at 43 cents per share, indicating a year-over-year decrease of 143.3%.
OSCR’s earnings beat estimates in three of the last four reported quarters, while missing in one.
Prudential Financial (PRU - Free Report) has an Earnings ESP of +0.85% and a Zacks Rank of 3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.42 per share, indicating a year-over-year decrease of 4.5%.
PRU’s earnings beat estimates in three of the last four reported quarters and missed in one.